Secukinumab in pregnancy: outcomes in psoriasis, psoriatic arthritis and ankylosing spondylitis from the global safety database

R B Warren; K Reich; R G Langley; B Strober; D Gladman; A Deodhar; T Bachhuber; W Bao; E Altemeyer; S Hussain; J Safi

doi:10.1111/bjd.16901

Secukinumab in pregnancy: outcomes in psoriasis, psoriatic arthritis and ankylosing spondylitis from the global safety database

R B Warren, K Reich, R G Langley, B Strober, D Gladman, A Deodhar, T Bachhuber, W Bao, E Altemeyer, S Hussain, J Safi

Division of Musculoskeletal & Dermatological Sciences (L5)

Research output: Contribution to journal › Letter › peer-review

481 Downloads (Pure)

Abstract

Psoriasis, psoriatic arthritis (PsA) and ankylosing spondylitis (AS) are chronic inflammatory conditions. Effective long term treatment may be necessary in women of childbearing age, but data concerning current treatments and pregnancy remain incomplete. Due to immunological changes, psoriasis and, to a lesser extent, PsA generally improve during pregnancy1,2 ; however, many pregnant patients still require treatment. This article is protected by copyright. All rights reserved.

Original language	English
Journal	The British journal of dermatology
Early online date	21 Jun 2018
DOIs	https://doi.org/10.1111/bjd.16901
Publication status	Published - 11 Sept 2018

Access to Document

10.1111/bjd.16901

Warren_et_al-2018-British_Journal_of_DermatologyAccepted author manuscript, 116 KB

Cite this

@article{3defb7614c5c4eb4ac8438e7f699cf28,

title = "Secukinumab in pregnancy: outcomes in psoriasis, psoriatic arthritis and ankylosing spondylitis from the global safety database",

abstract = "Psoriasis, psoriatic arthritis (PsA) and ankylosing spondylitis (AS) are chronic inflammatory conditions. Effective long term treatment may be necessary in women of childbearing age, but data concerning current treatments and pregnancy remain incomplete. Due to immunological changes, psoriasis and, to a lesser extent, PsA generally improve during pregnancy1,2 ; however, many pregnant patients still require treatment. This article is protected by copyright. All rights reserved.",

author = "Warren, {R B} and K Reich and Langley, {R G} and B Strober and D Gladman and A Deodhar and T Bachhuber and W Bao and E Altemeyer and S Hussain and J Safi",

year = "2018",

month = sep,

day = "11",

doi = "10.1111/bjd.16901",

language = "English",

journal = "The British journal of dermatology",

issn = "0007-0963",

publisher = "John Wiley & Sons Ltd",

}

TY - JOUR

T1 - Secukinumab in pregnancy

T2 - outcomes in psoriasis, psoriatic arthritis and ankylosing spondylitis from the global safety database

AU - Warren, R B

AU - Reich, K

AU - Langley, R G

AU - Strober, B

AU - Gladman, D

AU - Deodhar, A

AU - Bachhuber, T

AU - Bao, W

AU - Altemeyer, E

AU - Hussain, S

AU - Safi, J

PY - 2018/9/11

Y1 - 2018/9/11

N2 - Psoriasis, psoriatic arthritis (PsA) and ankylosing spondylitis (AS) are chronic inflammatory conditions. Effective long term treatment may be necessary in women of childbearing age, but data concerning current treatments and pregnancy remain incomplete. Due to immunological changes, psoriasis and, to a lesser extent, PsA generally improve during pregnancy1,2 ; however, many pregnant patients still require treatment. This article is protected by copyright. All rights reserved.

AB - Psoriasis, psoriatic arthritis (PsA) and ankylosing spondylitis (AS) are chronic inflammatory conditions. Effective long term treatment may be necessary in women of childbearing age, but data concerning current treatments and pregnancy remain incomplete. Due to immunological changes, psoriasis and, to a lesser extent, PsA generally improve during pregnancy1,2 ; however, many pregnant patients still require treatment. This article is protected by copyright. All rights reserved.

U2 - 10.1111/bjd.16901

DO - 10.1111/bjd.16901

M3 - Letter

C2 - 29927479

SN - 0007-0963

JO - The British journal of dermatology

JF - The British journal of dermatology

ER -

Secukinumab in pregnancy: outcomes in psoriasis, psoriatic arthritis and ankylosing spondylitis from the global safety database

Abstract

Access to Document

Fingerprint

Cite this